Drugs, at what price?

The emails began flowing in as news trickled out that India had, for the second time, cast its vote for public health. Pro-health groups from across the world, in their mailers, lauded India’s decision to stick with public health, rather than open itself to monopolies by honouring the patents on medicines.

Read Full Story>>